Sort   by:  
 Page size 
UnknownUrinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disorders.
Not available
S-EPMC3608516 | biostudies-literature
UnknownMulti-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology.
Not available
S-EPMC4575490 | biostudies-literature
UnknownSelf-reported treatment-associated symptoms among patients with urea cycle disorders participating in glycerol phenylbutyrate clinical trials.
Not available
S-EPMC4804346 | biostudies-literature
UnknownNovel ETF dehydrogenase mutations in a patient with mild glutaric aciduria type II and complex II-III deficiency in liver and muscle.
Not available
S-EPMC3970109 | biostudies-literature
UnknownRacial and Ethnic Differences in Genomic Profiling of Early Onset Colorectal Cancer.
Not available
S-EPMC9086761 | biostudies-literature
UnknownGlycerol phenylbutyrate treatment in children with urea cycle disorders: pooled analysis of short and long-term ammonia control and outcomes.
Not available
S-EPMC4382922 | biostudies-literature
UnknownElevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio.
Not available
S-EPMC4108288 | biostudies-literature
UnknownAmmonia control in children with urea cycle disorders (UCDs); phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate.
Not available
S-EPMC4880058 | biostudies-literature
UnknownPhase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: safety, pharmacokinetics and ammonia control.
Not available
S-EPMC2905228 | biostudies-literature
UnknownGlutamine and hyperammonemic crises in patients with urea cycle disorders.
Not available
S-EPMC4915945 | biostudies-literature
Sort   by:  
 Page size